af Björkesten, C., Ilus, T., Hallinen, T., Soini, E., Eberl, A., Hakala, K., . . . Sipponen, T. (2020). Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort. Eur J Gastroenterol Hepatol.
シカゴスタイル引用形af Björkesten, Clas-Göran, et al. "Objectively Assessed Disease Activity and Drug Persistence During Ustekinumab Treatment in a Nationwide Real-world Crohn’s Disease Cohort." Eur J Gastroenterol Hepatol 2020.
MLA引用形式af Björkesten, Clas-Göran, et al. "Objectively Assessed Disease Activity and Drug Persistence During Ustekinumab Treatment in a Nationwide Real-world Crohn’s Disease Cohort." Eur J Gastroenterol Hepatol 2020.
警告: この引用は必ずしも正確ではありません.